title: The role of microsatellite instability in cervical intraepithelial neoplasia and squamous cell carcinoma of the cervix.
abstract: OBJECTIVE
  This study was conducted to define the role of microsatellite instability (MSI) in cervical intraepithelial neoplasia (CIN) and squamous cell carcinoma (SCC) of the cervix. We also tested the validity of using markers recommended for MSI study in colonic carcinoma by the National Cancer Institute (NCI) for cervical neoplasm.
  
  
  METHODS
  Twenty normal cervical, 24 low-grade CIN (CIN-L), 59 high-grade CIN (CIN-H), and 93 SCC tissues were examined for MSI after microdissection. A polymerase chain reaction based MSI detection was performed using five markers recommended by the NCI for colonic cancer (panel one) as well as five other markers (panel two) found to be informative in earlier studies. High-frequency MSI (MSI-H) was defined as instability in > or = 2 of 5 loci if one panel was used and > or = 30% of loci when more than five loci were used. Low-frequency MSI (MSI-L) was diagnosed if instability was noted but did not meet the criteria of MSI-H. Findings were correlated with clinicopathologic information.
  
  
  RESULTS
  The combined use of panel one and two markers showed no MSI in normal cervical or CIN-L tissue, MSI-L in 1 CIN-H (1.7%), MSI-L in 16 (17.2%), and MSI-H in 11 (11.8%) SCC, respectively. The NCI-recommended panel alone detected 19 of 27 MSI-positive SCC. MSI-positive was not related to patient age, disease stage, and tumor grade. The overall survival of MSI-positive patients was significantly worse than that of microsatellite stable patients (P = 0.02). An increasing trend of MSI-H rate with higher disease stages was noted (P = 0.035) but MSI-H was not associated with poor prognosis.
  
  
  CONCLUSIONS
  The NCI recommended panel of markers might not be useful in MSI study for SCC and using more than five markers improves the MSI detection. MSI is rare in cervical dysplasia but is present in a subset of SCC. The association between MSI-positivity and prognosis awaits future confirmation.
authors.affiliation: Department of Obstetrics and Gynaecology, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, N.T., Hong Kong. yickfuwong@cuhk.edu.hk
authors.forename: Yick Fu
authors.initials: YF
authors.lastname: Wong
authors.forename: Tak Hong
authors.initials: TH
authors.lastname: Cheung
authors.forename: Kin Yan
authors.initials: KY
authors.lastname: Poon
authors.forename: Vivian Wei
authors.initials: VW
authors.lastname: Wang
authors.forename: James C B
authors.initials: JC
authors.lastname: Li
authors.forename: Keith Wing-Kit
authors.initials: KW
authors.lastname: Lo
authors.forename: So Fan
authors.initials: SF
authors.lastname: Yim
authors.forename: Mei Yung
authors.initials: MY
authors.lastname: Yu
authors.forename: Georgia
authors.initials: G
authors.lastname: Lahr
authors.forename: Tony Kwok-Hung
authors.initials: TK
authors.lastname: Chung
mesh_terms: D000328:Adult; D002294:Carcinoma, Squamous Cell / Q000235:genetics* / Q000473:pathology; D004273:DNA, Neoplasm / Q000097:blood / Q000235:genetics; D005260:Female; D006801:Humans; D018895:Microsatellite Repeats / Q000235:genetics*; D008875:Middle Aged; D009367:Neoplasm Staging; D016133:Polymerase Chain Reaction; D002583:Uterine Cervical Neoplasms / Q000235:genetics* / Q000473:pathology; D002578:Uterine Cervical Dysplasia / Q000235:genetics* / Q000473:pathology
chemical_list: D004273:DNA, Neoplasm